| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |